News >

Monoclonal Antibodies Shake Up Myeloma Paradigm

Kristi Rosa
Published: Monday, Apr 22, 2019

 Paul Richardson, MD
Paul Richardson, MD
The introduction of monoclonal antibodies into the treatment of relapsed/refractory multiple myeloma is one of the most important advances made in recent years, said Paul G. Richardson, MD. However, headway has also been made with small molecule inhibitors and CAR T-cell therapies, leaving investigators hopeful for the future.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication